Kinetic Capital Partners

Kinetic Capital Partners is a private equity and venture capital firm based in Vancouver, Canada, founded in 2002. The firm specializes in later-stage, pre-IPO, and buyout investments, primarily targeting sectors such as life sciences, healthcare, medical devices, software, and telecommunications. Kinetic Capital Partners focuses on growth-stage companies, especially those at the commercialization stage, and typically invests between $1 million and $25 million in equity capital. The firm aims for investments in businesses with enterprise values ranging from $35 million to $100 million and an EBITDA of at least $8 million, often seeking a majority stake to maintain a controlling ownership position. In addition to private equity investments, Kinetic Capital Partners occasionally engages in opportunistic public market investments.

Frank Barker

Partner

Dallas H Ross

Partner

22 past transactions

Moko Yogurt

Venture Round in 2023
Moko Yogurt is a brand that focuses on various floured yogurt drinks and provides sucrose-free products.

CXIP Labs

Seed Round in 2022
CXIP Labs is a developer of NFT infrastructure solutions for the web3 ecosystem.

BlockApps

Series B in 2022
BlockApps, Inc. is a Brooklyn-based company that specializes in developing a blockchain platform for building and deploying Ethereum applications. Its primary offering, BlockApps STRATO, is an Ethereum-compliant platform designed for the development, deployment, and management of enterprise blockchain applications. Additionally, BlockApps provides a STRATO consortium blockchain network, which serves as an enterprise-grade solution for creating hybrid private, consortium, and public blockchains. The company caters to a diverse clientele, including software startups, IT and professional services firms, industry-owned businesses, and Fortune 500 corporations. BlockApps has established a strategic partnership with Optimum and is recognized for its work with major enterprises and governments, further enhancing its reputation in the blockchain space. Founded in 2015, BlockApps is committed to facilitating digital ownership through innovative blockchain solutions.

WorldCoin

Venture Round in 2021
WorldCoin is a company that focuses on creating a privacy-centric digital currency platform designed to enhance global connectivity and trust among users. It offers a secure digital identity solution through its iris-scanning device, which generates a unique World ID, allowing individuals to manage their biometric information and digital assets securely. The platform operates on a permissionless blockchain, ensuring transparency and privacy in transactions. Additionally, the World App facilitates easy access to various Mini Apps while enabling users to store their World ID and digital assets effectively. By prioritizing user privacy, WorldCoin aims to discourage fraudulent activities and promote a trustworthy environment for digital interactions.

Dtravel

Seed Round in 2021
Dtravel is a decentralized platform designed for the home-sharing economy, enabling users to facilitate both short and long-term stays. By leveraging blockchain technology, Dtravel eliminates intermediaries in the vacation rental process, thereby empowering hosts and guests with greater ownership, control, and decision-making capabilities. The platform aims to enhance transparency and reduce fees within the home rental market, allowing guests to tailor their travel experiences more effectively. Through its innovative approach, Dtravel seeks to improve the relationship between participants in the home-sharing ecosystem while maintaining a focus on community engagement. The platform supports transactions in both cryptocurrency and traditional payment methods, making it accessible to a broader audience.

Jet Protocol

Seed Round in 2021
Jet Protocol Holdings is a developer of a decentralized lending and borrowing platform that aims to reduce transaction costs and enhance efficiency in financial transactions. The company specializes in creating innovative loan products and facilitates cross-chain interest rate arbitrage, allowing users to streamline their borrowing and lending activities. Through its platform, Jet Protocol Holdings provides a borrowing agreement designed to simplify the complexities often associated with traditional financial systems, making it easier for users to engage in lending and borrowing transactions.

Flare Network

Venture Round in 2021
Flare Networks is a blockchain network that utilizes the Flare Consensus Protocol, which is the first Turing Complete Federated Byzantine Agreement protocol. It offers a decentralized contract platform aimed at enhancing contract capabilities across various blockchains. By leveraging the Ethereum Virtual Machine, Flare Networks can access and utilize information from other blockchains and real-world data sources, effectively addressing the oracle problem. This functionality facilitates cross-chain interoperability, allowing users to share contract capabilities with different protocols. Flare Networks seeks to enable a new era of utility within the blockchain ecosystem through its innovative technology.

SubDAO

Funding Round in 2021
SubDAO Network operates a cross-chain Decentralized Autonomous Organization (DAO) protocol on Polkadot. It offers tools for creating and managing DAOs, facilitating cross-chain management with connected decentralized applications (DApps), and bridging Web 2.0 and Web 3.0 technologies. The platform provides digital agreement signing, DAO social networking, asset management, funding pool management, voting, and customization services to empower DAO creators and participants in governing their organizations.

Convergence Finance

Seed Round in 2021
Convergence Finance operates as a decentralized interchangeable asset protocol focused on facilitating the exchange of tokenized real-world assets. By leveraging blockchain technology and smart contracts, the company has developed a decentralized exchange platform that employs an automated market maker model. This innovative approach aims to enhance liquidity for tokenized assets, thereby transforming trading practices for both real-world and crypto-native investments. Convergence Finance prioritizes greater transparency and inclusivity, making it easier for all investors to access and trade these assets.

Terra

Venture Round in 2021
Terra is a price-stable cryptocurrency designed for mass adoption. It builds financial infrastructure for the next generation of decentralized applications. Terra is backed by Luna, a decentralized asset that derives its value from transaction fees collected on the Terra network. Much like the moon stabilizes the earth’s rotation, Luna is Terra's eternal guardian of stability.

CERE Network

Venture Round in 2021
CERE Network is a blockchain-based company that specializes in developing a customer relationship management (CRM) ecosystem designed for data integration and collaboration. Founded in 2019 and headquartered in San Francisco, California, CERE Network offers a platform that extracts customer data from various monolithic and disparate CRM and customer data platform systems. This platform provides an open micro-services environment that facilitates data collaboration and integration between businesses and vendors. Additionally, CERE Network utilizes blockchain technology to capture the entire customer journey, securely storing key user data such as purchases and achievements in user wallets. The company also introduces its own tokens, which are used for payment within its ecosystem.

Orange Schade

Seed Round in 2020
Orange Schade is a versatile company that specializes in auto body repair services and vehicle leasing solutions. It offers a comprehensive range of services, including damage repair recognized by Opel, car damage repair in Orange, and replacement vehicle services. The company has established a robust network of auto body repair shops, which enhances its ability to provide efficient and effective solutions for its customers. In addition, Orange Schade operates Special Lease, a leasing division that provides rental services, lease forms, and related offerings. With a focus on competitive pricing and high-quality service, the company tailors its lease terms to meet the diverse needs of its clientele, drawing on extensive experience in finance and insurance to support its operations.

Reef Finance

Seed Round in 2020
Reef Finance LLC is a decentralized finance platform that operates on the Polkadot blockchain. Founded in 2019 by CEO Denko Mancheski, the company is headquartered in Wilmington, Delaware. Reef Finance specializes in providing a liquidity aggregator and yield engine, facilitating trading by connecting users to liquidity from both centralized and decentralized exchanges. Its services include smart lending, borrowing, staking, and mining, all enhanced by an AI-driven personalized yield engine. As a pioneer in the Polkadot ecosystem, Reef Finance was notably the first project launched on Binance Launchpool, solidifying its position in the DeFi landscape.

Linear Finance

Seed Round in 2020
Linear Finance is a company that operates a decentralized delta-one asset protocol designed for cross-chain compatibility, facilitating the creation, management, and trading of synthetic assets with unlimited liquidity. The company serves various sectors, including cryptocurrency, commodities like crude oil and coffee, market indices, e-sports, and sustainability. Headquartered in New Territories, Hong Kong, Linear Finance leverages a blend of technical expertise from the cryptocurrency space and financial acumen from traditional asset management, enabling users to engage with assets efficiently and at fair market value.

ThunderCore

Series A in 2019
ThunderCore operates a high-performance public blockchain compatible with the Ethereum Virtual Machine (EVM). It employs a proprietary consensus protocol called PaLa, which addresses scalability challenges and enables rapid transaction processing at over 4,000 TPS with confirmation times under one second. The network's native currency, TT, facilitates secure and low-cost transactions, with gas fees costing less than a fraction of a cent. ThunderCore serves an international user base across over 190 countries, supporting decentralized applications (dApps) with enhanced security and scalability.

Eximchain

Initial Coin Offering in 2018
Eximchain is a company that provides a blockchain-based platform designed to streamline the global sourcing process for small and medium-sized enterprises. By offering a comprehensive service that includes data-driven analysis and customized recommendations, Eximchain connects businesses directly with suppliers while enhancing the reliability of these partnerships through a data-driven reputation system. The platform automates trade financing through smart contracts and facilitates the creation of trade documents, enabling seamless collaboration between importers and exporters. By utilizing blockchain technology, Eximchain removes traditional barriers in the supply chain, promoting a more efficient, transparent, and secure network for international trade. The company is headquartered in the United States.

Bluzelle

Initial Coin Offering in 2018
Bluzelle is a developer of a blockchain database aimed at addressing data storage and management challenges for decentralized applications. The company provides a comprehensive stack of blockchain applications, middleware, and data services tailored to meet the needs of a diverse clientele, from small and medium enterprises to global corporations. Its database solution features multi-region coverage and enhanced network security, ensuring scalability while minimizing environmental impact. Bluzelle's offerings enable developers to maintain up-to-date data that is both secure from hacking attempts and resistant to censorship, making it a valuable resource for businesses seeking innovative data management solutions.

VisCardia

Series B in 2017
VisCardia, Inc. is a medical device company based in Beaverton, Oregon, established in 2015. The company focuses on developing and commercializing a proprietary implantable therapy aimed at patients with refractory heart failure. VisCardia's innovative approach involves a fully implantable electronic sensor and electrode system that provides chronic electrical stimulation to enhance thoracic pressure. This therapy utilizes the patient's own thoracic musculature to improve cardiac filling and output, alleviating symptoms associated with hemodynamic insufficiency. By addressing the challenges faced by patients with severe heart conditions, VisCardia aims to offer a novel solution in the field of cardiac health.

Protiva Biotherapeutics

Venture Round in 2007
Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.

U-Systems

Venture Round in 2007
U-Systems is a developer and manufacturer of advanced ultrasound systems and software specifically designed to assist radiologists in the detection of breast cancer, particularly in women with dense breast tissue. The company’s innovative breast ultrasound systems produce 3D images that enhance visualization of targeted areas of concern within the breast. In addition to its focus on breast cancer diagnostics, U-Systems also designs and manufactures high-quality racking enclosures and cooling products aimed at reducing noise, heat, and costs in data centers and offices, utilizing innovative design principles and state-of-the-art manufacturing processes.

AgInfoLink

Series A in 2007
AgInfoLink Inc. designs and develops traceability solutions for the food industry. It offers data collection, secure data transmission, data warehousing, reporting, and analysis tools for linking information for individual animal management, regulatory compliance, and business performance. The company provides Pony Express, a data sharing solution to create and customize a data sharing network for supply chain; BeefLink, a personal computer-based data collection and management system to capture and store data automatically from RFID and barcode tags, scales, and other devices; AgInfoReports and AgInfoSheets reporting systems; and AgMobile, a handheld unit and wireless RFID reader that allows livestock producers to identify animals, record data, and reference historical data. AgInfoLink, Inc. also offers CattleCard, a data collection solution, for customers without computers, to collect group data and individual data using a barcode label sticker and RFID identifier; Tag Tracker, a rugged hand-held wireless RFID reader reads an RFID tag and communicates with a base station; and Animal Logger, a solution for collecting NAIS required and basic animal movement information, as well as WebReporting and Decision Pro tools, and processed verification programs. It serves state regulators, meat processors, retail/foodservice, and livestock producers. The company was founded in 1997 and is based in Longmont, Colorado.

Protiva Biotherapeutics

Series C in 2006
Protiva Biotherapeutics, Inc. is a biotechnology company in the development stage that specializes in nucleic acid-based pharmaceutical products. It aims to combat various human diseases, including cancer, influenza, Ebola, inflammatory diseases, and chronic viral infections. The company's product pipeline includes Pro 1, a tumor cell growth inhibitor; Pro-101, an siRNA product targeting tumor growth-related proteins; and Pro-B, which inhibits apolipoprotein B expression. Additionally, Protiva develops Pro-EBOV and Pro-MARV, which are designed to inhibit the replication of the Ebola and Marburg viruses, respectively. The company also employs Stable Nucleic-Acid Lipid Particle technology to facilitate the delivery of nucleic acid payloads to target cells. Furthermore, Protiva is engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics is headquartered in Seattle, Washington, with a research and development facility located in Vancouver, Canada. As of 2008, it operates as a subsidiary of Tekmira Pharmaceuticals Corp.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.